Clinical experience with infliximab for Crohn's disease: The first 100 patients in Edmonton, Alberta

Canadian Journal of Gastroenterology

Volumn 16, Issue 3, 2002, Pages 165-170

  Sample, Clifford ^a   Bailey, Robert J ^a   Todoruk, Dennis ^a   Sadowski, Daniel ^a   Gramlich, Leah ^a   Milan, Mario ^a   Cherry, Raeleen ^a   Ma, Mang ^a   Lalor, Eoin ^a   McKaigney, John ^a   Sherbaniuk, Richard ^a   Matic, Kata ^a   Switzer, Connie ^a   Fedorak, Richard N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Clinical remission; Clinical response; Crohn's disease; Immunosupression; Inflammatory bowel disease; Infliximab

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; DIPHENHYDRAMINE; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; PLACEBO; PREDNISONE; STEROID; TACROLIMUS;

ADULT; AGED; ANAPHYLAXIS; ARTHRALGIA; ARTICLE; CANADA; COLON FISTULA; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG INFUSION; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FOLLOW UP; GOUT; HEADACHE; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH; THORAX PAIN; VERTIGO;

EID: 0036107636     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/379307     Document Type: Article

References (11)

1. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
2. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
3. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
4. Successful management of Crohn's disease of the ileoanal pouch with infliximab
5. Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: The first 100 patients
6. Infliximab in Crohn's disease: First anniversary clinical experience
7. Clinical experience with infliximab: Therapy in 100 patients with Crohn's disease
8. Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of infliximab in Crohn's disease
9. Infliximab versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
10. The relationship between infliximab treatment and lymphoma in Crohn's disease
11. Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis